Ortin Global Limited (ORTINGLOBE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.597x

Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) has a cash flow conversion efficiency ratio of -0.597x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-7.75 Million ≈ $-83.86K USD) by net assets (Rs13.00 Million ≈ $140.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ORTINGLOBE net asset quality score to measure how much of total assets are equity-financed.

Ortin Global Limited - Cash Flow Conversion Efficiency Trend (2021–2026)

This chart illustrates how Ortin Global Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ortin Global Limited (ORTINGLOBE) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Ortin Global Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ortin Global Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
0.106x
Smartfren Telecom Tbk
JK:FREN
-0.016x
Elbit Med Tech
TA:EMTC
-0.005x
Peel Hunt Ltd
LSE:PEEL
0.134x
Fuse Cobalt Inc
V:FUSE
-0.057x
Gaucho Group Holdings Inc
NASDAQ:VINO
-0.853x
Europa Metals Ltd
JSE:EUZ
-0.110x
Arcadia Biosciences Inc
NASDAQ:RKDA
-0.208x

Annual Cash Flow Conversion Efficiency for Ortin Global Limited (2021–2026)

The table below shows the annual cash flow conversion efficiency of Ortin Global Limited from 2021 to 2026. For the full company profile with market capitalisation and key ratios, see Ortin Global Limited market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs12.37 Million
≈ $133.79K
Rs-5.62 Million
≈ $-60.76K
-0.454x -118.87%
2025-03-31 Rs19.77 Million
≈ $213.86K
Rs-4.10 Million
≈ $-44.37K
-0.207x +87.76%
2024-03-31 Rs28.24 Million
≈ $305.39K
Rs-47.87 Million
≈ $-517.71K
-1.695x -7171.33%
2023-03-31 Rs108.65 Million
≈ $1.17 Million
Rs-2.53 Million
≈ $-27.39K
-0.023x -111.89%
2022-03-31 Rs109.57 Million
≈ $1.18 Million
Rs21.48 Million
≈ $232.29K
0.196x -87.66%
2021-03-31 Rs113.56 Million
≈ $1.23 Million
Rs180.34 Million
≈ $1.95 Million
1.588x --

About Ortin Global Limited

NSE:ORTINGLOBE India Drug Manufacturers - Specialty & Generic
Market Cap
$1.36 Million
Rs126.04 Million INR
Market Cap Rank
#30350 Global
#1682 in India
Share Price
Rs15.50
Change (1 day)
+0.98%
52-Week Range
Rs11.19 - Rs19.92
All Time High
Rs19.92
About

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more